Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

ABBV-295

A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

AbbVie · Phase 1 · Completed · Enrollment 20

NCT07414784

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
ABBV-295 with Levonorgestrel and Ethinyl Estradioln/rn/rn/rn/r

Not shown

  • ABBV-295 with Levonorgestrel and Ethinyl Estradiol: endpoint not reported